Latest Prescription Drugs news
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Now Providing Daily Updates on Adverse Events
posted August 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
posted August 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
posted August 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Better Youth Fitness May Lower Risk for Depression in Adulthood Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
